122 related articles for article (PubMed ID: 21118419)
1. Pharmacokinetics of oral ivabradine in healthy cats.
Riesen SC; Ni W; Carnes CA; Lindsey KJ; Phelps MA; Schober KE
J Vet Pharmacol Ther; 2011 Oct; 34(5):469-75. PubMed ID: 21118419
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteers.
Vlase L; Neag M; Popa A; Muntean D; Bâldea I; Leucuta SE
J Clin Pharm Ther; 2011 Apr; 36(2):225-9. PubMed ID: 21366652
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a sensitive LC-MS/MS-ESI method for the determination of ivabradine in human plasma: application to a pharmacokinetic study.
Jiang J; Tian L; Huang Y; Li Y
Biomed Chromatogr; 2013 Dec; 27(12):1603-8. PubMed ID: 23798342
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction between ivabradine and phenytoin in healthy subjects.
Vlase L; Popa A; Neag M; Muntean D; Leucuta SE
Clin Drug Investig; 2012 Aug; 32(8):533-8. PubMed ID: 22765768
[TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic simulation model for ivabradine in healthy volunteers.
Duffull SB; Chabaud S; Nony P; Laveille C; Girard P; Aarons L
Eur J Pharm Sci; 2000; 10(4):285-94. PubMed ID: 10838018
[TBL] [Abstract][Full Text] [Related]
6. Determination of ivabradine and its N-demethylated metabolite in human plasma and urine, and in rat and dog plasma by a validated high-performance liquid chromatographic method with fluorescence detection.
Klippert P; Jeanniot JP; Polvé S; Lefèvre C; Merdjan H
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):125-33. PubMed ID: 9869372
[TBL] [Abstract][Full Text] [Related]
7. Population plasma and urine pharmacokinetics of ivabradine and its active metabolite S18982 in healthy Korean volunteers.
Choi HY; Bae KS; Cho SH; Ghim JL; Choe S; Jung JA; Lim HS
J Clin Pharmacol; 2016 Apr; 56(4):439-49. PubMed ID: 26265098
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of ivabradine and its metabolites in human plasma by liquid chromatography--tandem mass spectrometry.
François-Bouchard M; Simonin G; Bossant ; Boursier-Neyret C
J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(2):261-9. PubMed ID: 11043745
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects of ivabradine, a negative chronotropic agent, in healthy cats.
Cober RE; Schober KE; Buffington TC; Li X; Riesen SC; Bonagura JD
J Vet Cardiol; 2011 Dec; 13(4):231-42. PubMed ID: 22030291
[TBL] [Abstract][Full Text] [Related]
10. Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial.
Portolés A; Terleira A; Calvo A; Martínez I; Resplandy G
J Clin Pharmacol; 2006 Oct; 46(10):1188-94. PubMed ID: 16988208
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of sesamin on ivabradine metabolism in rats.
Xu RA; Sun W; Chen R; Liu N; Huang C
Pak J Pharm Sci; 2020 Nov; 33(6):2543-2546. PubMed ID: 33867328
[TBL] [Abstract][Full Text] [Related]
12. Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects.
Roth W; Bauer E; Heinzel G; Cornelissen PJ; van Tol RG; Jonkman JH; Zuiderwijk PB
J Pharm Sci; 1993 Jan; 82(1):99-106. PubMed ID: 8429501
[TBL] [Abstract][Full Text] [Related]
13. Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl.
King JN; Humbert-Droz E; Maurer M
J Vet Pharmacol Ther; 1999 Dec; 22(6):360-7. PubMed ID: 10651464
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
[TBL] [Abstract][Full Text] [Related]
15. The effect of clopidogrel on pharmacokinetics of ivabradine and its metabolite in rats.
Sun W; Wang Z; Chen H; Zhang XD; Huang CK; Lian QQ; Shang-Guan WN; Zhu GH; Hu GX; Wang ZS
Drug Dev Ind Pharm; 2015; 41(9):1512-7. PubMed ID: 25250618
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Silibinin on the Pharmacokinetics of Ivabradine and N-Desmethylivabradine in Rats.
Chen XP; Zheng HT; Cai WW; Li MK; Zhang JW; Hu J
Pharmacology; 2015; 96(3-4):107-11. PubMed ID: 26202095
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment with ivabradine and atenolol on reproducibility of echocardiographic indices of left heart size and function in healthy cats.
Riesen SC; Schober KE; Cervenec RM; Bonagura JD
J Vet Cardiol; 2012; 14(2):323-32. PubMed ID: 22578840
[TBL] [Abstract][Full Text] [Related]
18. An identifiability analysis of a parent-metabolite pharmacokinetic model for ivabradine.
Evans ND; Godfrey KR; Chapman MJ; Chappell MJ; Aarons L; Duffull SB
J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):93-105. PubMed ID: 11253617
[TBL] [Abstract][Full Text] [Related]
19. [Effects of stable isotope labeled internal standard on determination of ivabradine and N-demethylivabradine in human plasma].
Liu DQ; Yu JH; Zhang YF; Zhong DF; He L; Chen XY
Yao Xue Xue Bao; 2015 Mar; 50(3):348-54. PubMed ID: 26118116
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of amantadine in cats.
Siao KT; Pypendop BH; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2011 Dec; 34(6):599-604. PubMed ID: 21323678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
